Concepedia

Kalyan Dulla

KD

12

Publications

755

Citations

11

H-Index

2009

Active since

Affiliations

ProQR Therapeutics (Netherlands)(Current)

University College London

Erasmus MC

Radboud University Nijmegen

Philips (Netherlands)

Kalyan Dulla is an author at ProQR Therapeutics (Netherlands) specializing in medicine, molecular biology, and cell biology.

Top concepts

Publications per year

2009–2023

12

Publications

12

Splice-Modulating Oligonucleotide QR-110 Restores CEP290 mRNA and Function in Human c.2991+1655A>G LCA10 Models

Kalyan Dulla, Mònica Aguilà, Amelia Lane et al. · Molecular Therapy — Nucleic Acids · 2018 · 162 citations · Full text

, , +8

Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations

Kalyan Dulla, Ralph Slijkerman, Hester C. van Diepen et al. · Molecular Therapy · 2021 · 135 citations · Full text

Uncoupling of the spindle-checkpoint and chromosome-congression functions of BubR1

Sabine Elowe, Kalyan Dulla, Andreas Uldschmid et al. · Journal of Cell Science · 2009 · 117 citations

, , +15

Antisense Therapy for a Common Corneal Dystrophy Ameliorates TCF4 Repeat Expansion-Mediated Toxicity

Christina Zarouchlioti, Beatriz Sanchez-Pintado, Nathaniel J. Hafford‐Tear et al. · The American Journal of Human Genetics · 2018 · 90 citations · Full text

Quantitative Site-specific Phosphorylation Dynamics of Human Protein Kinases during Mitotic Progression

Kalyan Dulla, Henrik Daub, Renate Hornberger et al. · Molecular & Cellular Proteomics · 2010 · 54 citations · Full text

Rows per page

1–5 of 12